Filing Details
- Accession Number:
- 0001209191-22-040616
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-05 16:13:59
- Reporting Period:
- 2022-07-05
- Accepted Time:
- 2022-07-05 16:13:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1660334 | Verrica Pharmaceuticals Inc. | VRCA | Pharmaceutical Preparations (2834) | 463137900 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1805359 | G. Christopher Hayes | C/O Verrica Pharmaceuticals Inc. 44 West Gay Street, Suite 400 West Chester PA 19380 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-07-05 | 5,714 | $2.10 | 8,214 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
